These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7154732)

  • 1. [Circulating immune complexes in systemic lupus erythematosus].
    Font J; Cardellach F; Mirapeix E; Martorell J; Ingelmo M
    Med Clin (Barc); 1982 Dec 1-31; 79(10):478. PubMed ID: 7154732
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
    Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes and clinico-immunologic subtypes of systemic lupus erythematosus. II].
    Nasonov EL; Solov'ev SK; Poverennyĭ AM; Ivanova MM; Tachmuradova MD
    Ter Arkh; 1989; 61(5):38-43. PubMed ID: 2781488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deposited and circulating immune complexes in systemic lupus erythematosus].
    Cebecauer L; Zitnan D; Rovenský J
    Fysiatr Revmatol Vestn; 1971 Apr; 49(2):69-75. PubMed ID: 4102368
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: review.
    Alegretti AP; Schneider L; Piccoli AK; Xavier RM
    Cell Immunol; 2012; 277(1-2):1-7. PubMed ID: 22795896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement deficiency, immunocomplexes and lupus erythematosus].
    Vivanco Martínez F
    Rev Clin Esp; 1987 Mar; 180(5):264-8. PubMed ID: 3602524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement. Second of two parts.
    Walport MJ
    N Engl J Med; 2001 Apr; 344(15):1140-4. PubMed ID: 11297706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Solubility of immune complexes and activity of the alternative complement pathway in patients with systemic lupus erythematosus].
    Riera Cervantes N; Geffner J; Isturiz MA; Manni JA; de Bracco MM
    Rev Clin Esp; 1985 Oct; 177(6):254-7. PubMed ID: 4081196
    [No Abstract]   [Full Text] [Related]  

  • 11. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
    Medof ME; Scarborough D; Miller G
    Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations.
    Cairns SA; London A; Mallick NP
    Clin Exp Immunol; 1980 May; 40(2):273-82. PubMed ID: 7438538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
    Nydegger U; Lambert PH; Miescher PA
    Verh Dtsch Ges Inn Med; 1974; 80():1575-7. PubMed ID: 4217986
    [No Abstract]   [Full Text] [Related]  

  • 14. The pathogenetic significance of circulating immune complexes.
    Van Es LA; Daha MR; Valentijn RM; Kauffmann RH
    Neth J Med; 1984; 27(9):350-8. PubMed ID: 6083461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circulating immune complexes and NK activity in systemic lupus erythematosus].
    Haas H; Havel A; Lange A; Gross W; Flad HD; Schlaak M
    Immun Infekt; 1984 Apr; 12(2):109-10. PubMed ID: 6534842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing glomerular and tubulointerstitial patterns of injury in SLE.
    Couser WG; Salant DJ; Madaio MP; Adler S; Groggel GC
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):126-34. PubMed ID: 6213148
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R; Alarcón-Segovia D; Shoenfeld Y
    J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
    Hall RP; Lawley TJ; Heck JA; Katz SI
    Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA; Morris SM; Dash A; Peters DK
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complexes in SLE by polyethylenglycol precipitation-complement consumption test].
    Yotsumoto H; Shimokawa Y; Nomoto S; Tashiro M
    Nihon Hifuka Gakkai Zasshi; 1983 Feb; 93(3):287-90. PubMed ID: 6348349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.